Emerging evidences suggest that necrosis is programmed and is one of the main forms of cell death in the pathological process in cardiac diseases. Long noncoding RNAs (lncRNAs) are emerging as new players in gene regulation. However, it is not yet clear whether lncRNAs can regulate necrosis in cardiomyocytes. Here, we report that a long noncoding RNA, named necrosis-related factor (NRF), regulates cardiomyocytes necrosis by targeting miR-873 and RIPK1 (receptor-interacting serine/threonine-protein kinase 1)/RIPK3 (receptor-interacting serine/threonine-protein kinase 3). Our results show that RIPK1 and RIPK3 participate in H 2 O 2 -induced cardiomyocytes necrosis. miR-873 suppresses the translation of RIPK1/RIPK3 and inhibits RIPK1/RIPK3-mediated necrotic cell death in cardiomyocytes. miR-873 reduces myocardial infarct size upon ischemia/reperfusion (I/R) injury in the animal model. In exploring the molecular mechanism by which miR-873 expression is regulated, we identify NRF as an endogenous sponge RNA and repress miR-873 expression. NRF directly binds to miR-873 and regulates RIPK1/RIPK3 expression and necrosis. Knockdown of NRF antagonizes necrosis in cardiomyocytes and reduces necrosis and myocardial infarction upon I/R injury. Further, we identify that p53 transcriptionally activates NRF expression. P53 regulates cardiomyocytes necrosis and myocardial I/R injury through NRF and miR-873.Our results identify a novel mechanism involving NRF and miR-873 in regulating programmed necrosis in the heart and suggest a potential therapeutic avenue for cardiovascular diseases.
Apoptosis has long been thought as the only prototype of programmed cell death and necrosis is traditionally regarded passive and unregulated form of cell death. Emerging evidences indicate that programmed necrosis is a backup cell death program that is activated when apoptotic cell death is blocked. 1, 2 It has been demonstrated that necrotic cell death can be tightly regulated by distinct molecules, and the identification of some specific programmed necrotic regulators make it conceivable that necrotic cell death is not only an independent and specialized form of cell death, but that it is also programmed. [3] [4] [5] Recent studies have suggested that necrosis is related to various cardiac diseases and is a major contributor to loss of cardiomyocytes cell death. [6] [7] [8] [9] However, the molecular mechanisms of programmed necrosis in the heart are unclear relative to apoptosis. New molecules and pathways need to be further discovered.
Death receptors have been shown to induce a particular type of necrotic death in certain cell type, termed programmed necrosis or necroptosis, which is mediated by the receptorinteracting serine/threonine-protein kinase (RIPK) 1 and 3. [10] [11] [12] RIPK1 is essential in TNF-α, TRAIL and CD95 ligand-induced necrotic cell death. Upon induction of necrosis, RIPK1 and 3 form a necrosis-inducing complex together. 12 RIPK3 phosphorylates the mixed lineage kinase domain-like protein (MLKL) and is a key determinant in mediating the RIPK1 necrotic signaling pathway. 13 Inhibition of MLKL blocks the necrotic pathway upon RIPK3 activation and arrest necrosis. 13 RIPK1 and RIPK3 have recently been shown to be activated in ischemia heart. 5, 14 However, it is not yet clear whether RIPK1 or RIPK3 is a target of microRNAs (miRNAs) and the molecular regulation of RIPK1 or RIPK3 in the programmed necrotic machinery remains to be elucidated in the heart. Addressing these questions will be of great importance to decipher and characterize the molecular pathway of necrosis.
miRNAs are a class of small noncoding RNAs that provide post-transcriptional regulation of gene expression. miRNAs control many cellular processes, including differentiation, proliferation and apoptosis. [15] [16] [17] [18] [19] [20] miRNAs also participate in many physiological and pathological processes in cardiovascular health and disease. [21] [22] [23] In particular, miRNAs may contribute to the pathophysiological consequences of myocardial infarction, and the alteration of miRNAs levels during apoptosis is reported as a novel therapeutic strategy for cardiac diseases. 21, 24, 25 However, it is not yet clear whether miRNAs are involved in the regulation of programmed necrosis by targeting RIPK1/RIPK3 in the heart.
Long noncoding RNAs (LncRNAs) are endogenous regulatory RNAs molecules that do not code for proteins but influence a vast array of biologic processes. 26 LncRNAs contain over 200 nucleotides and emerge as new regulators in a wide variety of biological processes, including RNA splicing, epigenetic regulation, cancer generation and development. [27] [28] [29] [30] Recent studies suggest critical roles of lncRNAs in mediating the initiation and progression of cardiovascular diseases, and lncRNAs have emerged as novel therapeutic targets in cardiovascular medicine. [31] [32] [33] [34] Although lncRNAs play essential roles in various biological processes, hitherto, it is not yet clear whether lncRNAs are involved in the regulation of programmed necrosis in the heart.
Our present work aims at finding out molecules and signaling pathway that are able to regulate cardiomyocyte necrosis. miR-873 was found to participate in the regulation of cardiomyocyte necrosis by targeting RIPK1/RIPK3. miR-873 regulated the expression of RIPK1/RIPK3 by blocking their translation. In searching for the upstream regulator of miR-873, we identified that lncRNA NRF acted as an endogenous sponge that repressed the expression of miR-873. In addition, we demonstrated that NRF can be transcriptionally activated by p53. p53 regulates NRF expression and the consequent cardiomyocyte necrosis through miR-873. The newly identified p53-NRF-miR-873-RIPK1/ RIPK3 pathway provides new insight into miR-873 function and lncRNA biology in cardiovascular diseases.
Results miR-873 participates in the regulation of RIPK1 and RIPK3 expression. It is well known that hydrogen peroxide (H 2 O 2 ) is an important factor inducing cell death. However, the form of cell death induced by H 2 O 2 varies from apoptosis to necrosis, depending on the exact concentration applied and the cell type tested. [35] [36] [37] We tested the effect of H 2 O 2 on cardiomyocytes death and observed that treatment with 0.2 mM H 2 O 2 only triggered apoptosis (Supplementary Figure S1A ), while the concentration of 0.6 mM H 2 O 2 preferentially caused necrosis (Supplementary Figure S1B ). RIPK1 and RIPK3 are the two critical signaling molecules that mediate the programmed necrosis pathway. [10] [11] [12] We firstly tested whether RIPK1 and RIPK3 participated in H 2 O 2induced cardiomyocytes necrosis. Noticeably, RIPK1 and RIPK3 were dramatically elevated in cardiomyocytes exposed to 600 μM H 2 O 2 (Figure 1a ). In the infarcted human hearts, RIPK1 and RIPK3 levels were also markedly increased compared with control hearts (Supplementary Figure S2A ). We generated siRNA constructs for RIPK1 and RIPK3, respectively ( Supplementary Figures S2B and C To explore the underlying mechanism by which RIPK1 and RIPK3 were upregulated upon H 2 O 2 , we tested whether miRNA could control RIPK1 and RIPK3 expression. We analyzed the 3′ untranslated region (UTR) sequence of RIPK1 and RIPK3 by the bioinformatic program TargetScan. We found eight potential miRNAs, each of which had a binding site in the RIPK1 3′UTR and RIPK3 3′UTR. We tested whether these miRNAs could regulate RIPK1 and RIPK3 expression and noticed that only miR-873 resulted in an obvious reduction of RIPK1 and RIPK3 protein levels (Figures 1d and e ), whereas other several miRNAs had no effect on the expression of RIPK1 and RIPK3 (Supplementary Figures  S3A-G) . The inhibitory effect of miR-873 on RIPK1 and RIPK3 expression prompted us to test whether RIPK1 and RIPK3 are downstream targets of miR-873 in controlling necrosis. The mRNA levels of RIPK1 and RIPK3 were not altered upon miR-873 treatment ( Supplementary Figures S4A-C) . Administration of miR-873 antagomir (Supplementary Figure S4D ) induced an elevation of RIPK1 and RIPK3 protein levels ( Figure 1f ) but not mRNA levels (Supplementary Figures S4E and F). Enforced expression of miR-873 attenuated the increase in RIPK1 and RIPK3 protein levels upon H 2 O 2 treatment ( Figure 1g ). Thus, it seems that miR-873 regulates RIPK1 and RIPK3 expression at post-transcriptional level. To learn whether RIPK1 and RIPK3 are direct targets of miR-873, we employed the luciferase reporter assay system to test the effect of miR-873 on the translation of RIPK1 and RIPK3. The luciferase reporter assay revealed that miR-873 overexpression induced a decrease in the luciferase activity ( Figure 1h ). The introduction of mutations in the miR-873 substantially reduced the inhibitory effects of miR-873 ( Figures 1d and h) . Taken together, it suggests that RIPK1 and RIPK3 are specific targets of miR-873. miR-873 regulates H 2 O 2 -induced necrosis through RIPK1 and RIPK3. Subsequently, we tested whether miR-873 plays an important role in cardiomyocytes necrosis. We firstly detected miR-873 levels and observed that the expression of miR-873 was markedly reduced in the infarcted human hearts (Figure 2a ) and in cardiomyocytes exposed to 600 μM H 2 O 2 (Figure 2b ). Next, we explored the role of miR-873 in cardiomyocytes necrosis. Electron microscopy was performed to detect the morphological hallmarks of cardiomyocytes. Cardiomyocytes upon exposure to 600 μM H 2 O 2 displayed obvious necrotic morphological characterization such as increase of cell volume, dilation of organelles, rupture of the plasma membrane and loss of cell integrity ( Figure 2c ). However, enforced expression of miR-873 attenuated the necrotic morphological hallmarks ( Figure 2c ). In addition, miR-873 also diminished H 2 O 2induced necrotic cell death, as assessed by propidium iodide (PI) exclusion ( Figure 2d ). These results indicate an inhibitory effect of miR-873 in cardiomyocytes necrosis. We then explored how miR-873 exerts its effect on necrotic program. Since miR-873 is able to suppress RIPK1/RIPK3 expression, we thus tested whether miR-873 regulated necrosis by targeting RIPK1/RIPK3 in cardiomyocytes. To confirm the relationship between miR-873 and RIPK1/RIPK3 in necrosis program machinery, we employed the target protector technology in which a target protector is able to disrupt the specific interaction of miRNA-mRNA pairs. To this end, we produced RIPK1 and RIPK3 target protector, respectively, and observed that the inhibitory effects of miR-873 on RIPK1/RIPK3 expression and necrotic cell death were significantly abolished in the presence of RIPK1/RIPK3 target protector (Figures 2e and f) . These results reveal that miR-873 inhibits necrotic cell death by targeting RIPK1/RIPK3. miR-873 regulates necrotic cell death in the heart. Having demonstrated that miR-873 was involved in H 2 O 2 -induced necrosis by targeting RIPK1/RIPK3 in vitro, we further investigated the role of miR-873 and RIPK1/RIPK3 in the pathogenesis of cardiac infarction in the animal model. Mouse model of ischemia/reperfusion (I/R) is widely used for the study of cardiac infarction and I/R has been documented to induce necrosis in the heart. 38 miR-873 levels were reduced in response to I/R injury in the ischemic zone but not in the remote zone of heart ( Figure 3a ). I/R led to an increase in RIPK1/RIPK3 expression, and this increase was attenuated in the presence of miR-873 (Supplementary Figure S4G and Figure 3b ). The myosin antibody injection technique was used to assess myocardial necrosis in vivo. 38 I/R caused a massive increase in necrotic myosin-positive cells (Figure 3c ), whereas the administration of miR-873 resulted in a decrease in the myocardial necrosis ( Figure 3c ). The administration of miR-873 also reduced myocardial infarct sizes ( Figure 3d ). Echocardiography on animals revealed that miR-873-administrated mice displayed a decrease in left ventricular internal diameter ( Figure 3e ) and an amelioration in cardiac function, as indicated by increased fractional shortening ( Figure 3f ). Thus, our results strongly suggest a possible contribution of miR-873 in inhibiting necrosis in I/R injured heart.
NRF interacts with miR-873 and regulates miR-873 expression. Recent studies have suggested that lncRNAs may act as an endogenous sponge RNA to interact with miRNAs and influence the expression of miRNA. [39] [40] [41] To explore the underlying mechanism responsible for miR-873 downregulation in response to H 2 O 2 and I/R treatment, we tested whether lncRNA could participate in the regulation of miR-873 expression. We carried out quantitative reverse transcription polymerase chain reaction (qRT-PCR) to detect lncRNAs levels in response to H 2 O 2 treatment. LncRNAs were chosen from the lncRNA array published online by Fantom company. Among those lncRNAs, five lncRNAs were substantially elevated ( Figure 4a ). To understand which lncRNA is involved in the regulation of miR-873, we separately knocked down the five lncRNAs by siRNA constructs. The results showed that only knockdown of AK047645 (Supplementary Figure S5A ) which we named necrosis-related factor (NRF), led to an increase of miR-873 expression levels ( Figure 4b ) and the other four lncRNAs had no effect on the miR-873 expression. Enforced expression of NRF (Supplementary Figure S5B ) induced a reduction in miR-873 levels (Figure 4c ).
To understand the mechanism by which NRF regulates the levels of miR-873, we tested whether NRF could interact with miR-873. We compared the sequences of NRF with that of miR-873 using the bioinformatics program RNAhybrid and noticed that NRF contains a binding site of miR-873 ( Figure 4d ). Further, we applied a biotin-avidin pull-down system to test whether miR-873 could directly bind to NRF. Cardiomyocytes were transfected with biotinylated miR-873, and then harvested for biotin-based pull-down assay. NRF was pulled down by biotinylated wild-type miR-873, but the introduction of mutations that disrupt base pairing between NRF and miR-873 (Supplementary Figure S5C ) led to the inability of miR-873 to pull-down NRF (Figure 4e ), indicating that the recognition of miR-873 to NRF is sequence specific. We also employed inverse pull-down assay to test if NRF could pull-down miR-873, a biotin-labeled-specific NRF probe was used. The results showed that miR-873 could be co-precipitated by NRF ( Figure 4f ). Further, we detected the subcellular location of NRF and miR-873. It showed that NRF was expressed both in nucleus and cytoplasm and miR-873 was mainly expressed in the cytoplasm (Figure 4g ). So we applied the biotin-labeled-specific NRF probe to assay where the interaction between NRF and miR-873 occurs. The results showed that miR-873 could be co-precipitated by NRF in the cytoplasm (Figure 4h ), but not in the nucleus (Figure 4i ). Taken together, it appears that NRF is able to directly bind to miR-873 and regulate miR-873 levels.
NRF regulates necrosis through targeting miR-873 and RIPK1/RIPK3. Since NRF can interact with miR-873, we tested whether NRF is able to regulate necrosis through miR-873 and RIPK1/RIPK3. Knockdown of NRF reduced RIPK1/RIPK3 levels (Figure 5a ). Overexpression of NRF resulted in the upregulation of RIPK1/RIPK3 expression levels (Figure 5b) . NRF counteracted the inhibitory effect of miR-873 on RIPK1/RIPK3 expression ( Figure 5c ).
We then explored the effect of NRF on necrosis. Knockdown of NRF inhibited necrosis induced by H 2 O 2 in cardiomyocytes ( Figure 5d ). In animal model, NRF levels were increased in response to I/R injury in the ischemic zone (Figure 5e ). Knockdown of NRF resulted in a decrease in the myocardial (Figure 5f and g) and reduced myocardial infarct sizes (Figure 5h ). The cardiac function as revealed by fractional shortening was also ameliorated in the NRF knockdown group (Figure 5i ). These results indicate that NRF participates in the regulation of cardiomyocytes necrosis and myocardial infarction. Subsequently, we considered whether RIPK1/RIPK3 downregulation by miR-873 contributed to the function of NRF on necrotic cell death. We knocked down the endogenous miR-873 by antagomir, and observed that the inhibitory effect of NRF knockdown on RIPK1/RIPK3 expression (Supplementary Figure S6A ) and necrotic cell death (Supplementary Figure S6B) were attenuated in the absence of miR-873. Taken together, these data suggest that NRF mediates necrotic cell death in cardiomyocytes through modulating miR-873-RIPK1/RIPK3 signaling pathway.
p53 regulates NRF expression in transcriptional level. It is reported that mRNAs and miRNAs both can be regulated by transcriptional factors. Thus, we then tested whether NRF also could be regulated at the transcriptional level. We analyzed the promoter region of mouse NRF and observed that there is a potential binding site of p53 (Figure 6a ). Then, we tested whether p53 could influence NRF promoter activity. Wild-type NRF promoter (wt) presented a high activity in the presence of p53. And mutations in the p53-binding site (Figure 6b ).
Enforced expression of p53 led to an increase in NRF expression levels (Figure 6c ), whereas knockdown of p53 exhibited a decreased expression levels of NRF (Figure 6d ), suggesting that NRF may be a potential transcriptional target of p53. Thus, we tested whether p53 could bind to the promoter region of NRF. The chromatin immunoprecipitation (ChIP)-quantitative PCR (qPCR) assay revealed that p53 bound to the NRF promoter under the physiological condition. H 2 O 2 treatment enhanced the association of p53 with the NRF promoter ( Figure 6e ). We further demonstrated that H 2 O 2 induced an elevation in NRF promoter activity in cardiomyocytes (Figure 6f ). Concomitantly, knockdown of p53 attenuated the increase of NRF promoter activity upon H 2 O 2 treatment (Figure 6f ). These data indicate that NRF can be transcriptionally activated by p53.
p53 regulates necrosis through NRF, miR-873 and RIPK1/ RIPK3. We investigated the role of p53 in cardiomyocytes necrosis and myocardial infarction. H 2 O 2 induced an elevation in p53 expression levels (Figure 7a ). Knockdown of p53 increased the expression levels of miR-873 ( Figure 7b ), and attenuated RIPK1/RIPK3 expression (Supplementary Figure S7A ) and necrotic cell death (Figure 7c ) upon H 2 O 2 treatment in cardiomyocytes. In vivo, p53 levels were also increased in mouse hearts upon I/R injury (Figure 7d ) and in the infarcted human hearts (Supplementary Figure S7B) . Knockdown of p53 resulted in a decrease in the myocardial necrosis ( Figure 7e ) and reduced myocardial infarct sizes (Figure 7f ). These data indicate that p53 participates in mediating the signal for necrotic cell death in the heart.
We further tested whether miR-873 and RIPK1/RIPK3 could act as the downstream targets of p53 in necrotic signal pathway. We observed that knockdown of miR-873 attenuated the inhibitory effect of p53 knockdown on RIPK1/RIPK3 expression ( Figure 7g ) and necrotic cell death (Figure 7h ).
Thus, it appears that p53 targets NRF, miR-873 and RIPK1/ RIPK3 axis in the necrotic cascades.
Discussion
Although the function of miRNAs has been widely studied in cardiomyocytes, the mechanism of miRNAs regulating programmed necrosis in the heart remains largely unknown. miR-873 has been demonstrated to be involved in the pathogenesis of experimental autoimmune encephalomyelitis 42 and human T-cell leukemia virus type 1 (HTLV-1). 43 But the function of miR-873 in the heart is unclear.
Our present study demonstrated that miR-873 participated in the regulation of programmed necrosis and myocardial infarction through targeting RIPK1/RIPK3 in cardiomyocyte. miR-873 has been revealed to be downregulated in colorectal cancer and glioblastoma. 44, 45 Whether miR-873 is involved in the regulation of necrosis in other tissues or cell types such as cancer is an interesting question for future investigation. Our study has provided important evidences about the function of miRNAs in the programmed necrosis pathway, a step toward better understanding the miRNA-based therapy for I/R injury and heart failure.
The major breakthrough in the study of programmed necrosis comes from the discovery RIPK1 46 and RIPK3, 10, 12 the enzymatic activity of which are important in the execution of necrosis. RIPK1 and RIPK3 are essential for TNF α-induced programmed necrosis. 46, 47 Knockdown of RIPK1 and RIPK3 significantly attenuates TNF-induced necrosis in human and mouse cells. 48 The present study demonstrated that RIPK1 and RIPK3 participated in the regulation of programmed necrosis induced by H 2 O 2 in cardiomyocytes. Consistent with previous studies, data from this study further supported the critical role of RIPK1 and RIPK3 in necrotic cell death. In addition, several death receptors have been reported to mediate necrotic cell death upon activation of RIPK1 and RIPK3, such as TNFR1, 49 TNFR2 50 and DR4/5. 51 RIP and TRAF2 form a complex upon oxidative stress-induced cell death, but without the participation of TNFR1. 50 It remains to be further determined whether the programmed necrosis induced by H 2 O 2 treatment in cardiomyocyte also require some of the signaling molecules such TRAF2/ TNFR1/TNFR2 to convey the cell death signals.
LncRNAs have been defined to play critical roles in diverse physiological and pathological processes. [27] [28] [29] 52 Despite the biological importance of lncRNAs, it is not yet clear whether lncRNAs is involved in the regulation of necrosis. The present work reveals a novel function of lncRNA in regulating cardiomyocyte necrosis. Our results showed that knockdown of lncRNA NRF attenuated H 2 O 2 -induced necrotic responses in cardiomyocytes and reduced myocardial infracted sizes upon I/R injury. This work provides a new clue for the understanding of lncRNAs-controlled cellular events. The discovery of NRF in necrotic cell death may shed new light on understanding the complex molecular mechanisms of cardiac infarction.
Emerging evidences suggest that lncRNAs may act as endogenous sponge RNAs to interact with miRNAs and influence the expression of miRNA target genes. Hmga2 regulates let-7 activity and promotes lung cancer progression by acting like an endogenous competing RNA for let-7. 53 Highly upregulated liver cancer acts as an endogenous 'sponge', which downregulates miR-372 leading to reducing translational repression of its target gene, PRKACB. 40 Consist with these reports, our results showed that lncRNA NRF served as a miR-873 sponge and reduced the expression of miR-873. We speculate that there may exist some mechanisms that can degrade part of the binding miRNA, which is similar to the function of antagomirs that promote the degradation of miRNA. [54] [55] [56] But the exact mechanism is still unclear. It is also an interesting scientific topic and we will focus on that in our future research.
The importance of p53 has been found in all major human cancers. It is a tumor suppressor that enforces normal growth control and genomic stability. Also, p53 acts as a transcription factor and regulates a number of genes that promote apoptosis. 57 However, few studies have been focused on the p53 function in cell necrosis. A recent study shows that p53 promotes necrotic cell death by interacting with CypD in mouse embryo fibroblasts. 58 Consistent with the previous study, our present work further demonstrated the role of p53 in promoting necrotic cell death. In addition, a couple of studies have revealed that H 2 O 2 caused the alteration of p53 modifications other than its protein level. For example, H 2 O 2 increases p53 acetylation by NAD(+)-dependent deacetylase SIRT1. 59 H 2 O 2 can induce p53 acetylation at Lys-305 and Lys-382. 60 Exposure of fibroblast to H 2 O 2 induces phosphorylation of p53. 61 And H 2 O 2 promotes translocation of p53 from cytosol into the nuclei in the oligodendroglia-like cell line. 62 In cardiomyocytes, H 2 O 2 not only can markedly increase the expression level of p53 but also can enhance phosphorylation of p53. 63 In our study, the increase in p53 expression level upon H 2 O 2 treatment is the major contributor to the transcription activation of NRF. Modulation of p53 or NRF levels may provide a new approach for tackling necrotic cell death and myocardial infarction. It is of great interesting to study whether modifications of p53, such as acetylation and phosphorylation, are also changed during activation of NRF signaling pathway. And in the future we will exert our effort to elucidate the functions of p53 modifications in necrosis.
Hitherto, knowledge about regulators of programmed necrosis remains glaringly incomplete. Our results provide novel evidences demonstrating that p53-NRF-miR-873-RIPK1/RIPK3 constitutes an axis in regulating cardiomyocyte necrosis. Our results reveal that transcription factors, lncRNAs, miRNAs and protein kinases work in concert and orchestrate a cardiomyocyte necrosis pathway. This pathway defines physiological and pathological roles of programmed necrosis in cardiomyocyte in greater detail. Future studies are needed to elucidate how this pathway is integrated into complex necrotic cascades. Our discovery promotes therapeutic interventions for cardiac diseases based on the knowledge of programmed necrosis in the heart. With time, we will discover more and more de novo and inspiring mechanisms that modify necrotic pathways in the heart.
Materials and Methods
Cardiomyocytes culture and treatment. Cardiomyocytes were isolated from 1-to 2-day-old mice as we described. 64 Briefly, after dissection hearts were washed, minced in HEPES-buffered saline solution. Tissues were then dispersed in a series of incubations at 37°C in HEPES-buffered saline solution containing 1.2 mg/ml pancreatin and 0.14 mg/ml collagenase (Worthington, Lakewood, NJ, USA). After centrifugation cells were re-suspended in Dulbecco's modified Eagle's medium/F-12 (GIBCO, Grand Island, NY, USA) containing 5% heat-inactivated horse serum, 0.1 mM ascorbate, insulin-transferring-sodium selenite media supplement (Sigma, St Louis, MO, USA), 100 U/ml penicillin, 100 μg/ml streptomycin and 0.1 mM bromodeoxyuridine. The dissociated cells were pre-plated at 37°C for 1 h. The cells were then diluted to 1 × 10 6 cells/ml and plated in 10 μg/ml laminin-coated different culture dishes according to the specific experimental requirements. Cells were treated with 200 or 600 μM H 2 O 2 except as otherwise indicated elsewhere. Necrotic cell death was assessed by PI exclusion.
Cell transfection with miR-873 duplexes or antagomirs. The miR-873 duplexes were synthesized by GenePharma Co. Ltd (Shanghai, China). MiR-873 mimic sequence was 5′-GCAGGAACUUGUGAGUCUCCU-3′. MiR-873 mutant sequence was 5′-GACAACCCUUGUGAGUCUCCU-3′. Mimic control sequence was 5′-CAGUACUUUUGUGUAGUACAA-3′. Chemically modified antisense oligonucleotides (antagomirs) were used to inhibit endogenous miR-873 expression. The antagomir sequence was 5′-AGGAGACUCACAAGUUCCUGC-3′. The antagomir control sequence was 5′-CAGUACUUUUGUGUAGUACAA-3′. All the bases were 2 0 -O-methyl-modified (GenePharma Co. Ltd). Cells were transfected with miRNA duplexes (50 nM) or antagomirs (50 nM) using Lipofectamine 2000 (Invitrogen, GrandIsland, NY, USA) according to the manufacturer's instructions.
Target protector preparation and transfection. Target protector was designed and named as others and we described. 65 In brief, RIPK1-TP miR-873 sequence is 5′-CTTCAGGAAAGCCTGGAACCTTCCC-3′, RIPK3-TP miR-873 sequence is 5′-CTTCAGGAAGTGGCAAGGACTGTCT-3′, TP control sequence is 5′-TGACAAATGAGACTCTCTCCTCTCC-3′. They were synthesized by Gene Tools (Philomath, OR, USA), and transfected into the cells using the Endo-Porter kit (Gene Tools) according to the kit's instructions.
qRT-PCR. Stem-loop qRT-PCR for mature miR-873 was performed as described 66 on a CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). Total RNA was extracted using Trizol reagent. After DNAse I (Takara, Japan) treatment, RNA was reverse transcribed with reverse transcriptase (ReverTra Ace, Toyobo). The levels of miR-873 analyzed by qRT-PCR were normalized to that of U6. U6 primers were forward: 5′-GCTTCGGCAGCACATA TACTAA-3′; reverse: 5′-AACGCTTCACGAATTTGCGT-3′. qRT-PCR for NRF were performed as we described. 64 The sequences of NRF primers were forward: 5′-CAGAAGGCAAACTGCCTCTGTT-3′; reverse: 5′-GTTAAAAGTTGATACCAAC AGTG-3′. The results were standardized to control values of glyceraldehyde-3phosphate dehydrogenase (GAPDH). GAPDH forward primer: 5′-TGTGTCCGTCG TGGATCTGA-3′; reverse: 5′-CCTGCTTCACCACCTTCTTGA-3′. The specificity of the PCR amplification was confirmed by agarose gel electrophoresis.
Immunoblot. Immunoblot was performed as we described. 67 The anti-RIPK1, anti-RIPK3 and anti-Tubulin antibodies were from Abcam (GrandIsland, NY, USA). The anti-p53 and anti-PCNA antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The horseradish peroxidase-conjugated secondary antibodies were purchased from Santa Cruz Biotechnology, Inc.
Constructions of adenoviruses harboring mouse NRF, NRF-siRNA, RIPK1-siRNA, RIPK3-siRNA and p53-siRNA. To construct adenovirus encoding NRF, NRF was synthesized by PCR using mouse cDNA as the template. The forward primer was 5′-ATTTTTTGGTTATTTCTGACTAGTAC-3′; the reverse primer was 5′-GAAGTATGTTGTTTATTTTTCTATAA-3′. The PCR fragment was finally cloned into the Adeno-X Expression System (Clontech, Otsu, Japan) according to the manufacturer's instructions. The mouse NRF RNAi target sequence is 5′-GGGACAGAGGCCTGTTTGC-3′. A nonrelated, scrambled RNAi without any other match in the mouse genomic sequence was used as a control (5′-GTAGCC GATGTCGAGTGCG-3′). The mouse RIPK1 target sequence is 5′-CAACCGCGCT GAGTACAAT-3′ and the scramble sequence is 5′-CACAGTAGCTCAGACTACG-3′. The mouse RIPK3 target sequence is 5′-ACACGGCACTCCTTGGTAT-3′ and the scramble sequence is 5′-CTGACTCAGTACTAGCTCG-3′. P53 siRNA sequence is 5′-CACATGACGGAGGTCGTGA-3′; the scramble p53-siRNA sequence is 5′-GAC GTATGCATAGTCGTCA-3′. The adenoviruses harboring these RNAi constructs were generated using the pSilencer adeno 1.0-CMV System (Ambion, GrandIsland, NY, USA) according to the Kit's instructions.
The luciferase constructs of RIPK1 3′UTR and RIPK3 3′UTR. RIPK1 3′UTR was amplified by PCR. The forward primer was 5′-CCAGACAAGGTT TCTCAGTTCTC-3′; the reverse primer was 5′-TCTGAAGCACCTATCTTCAGCAG-3′. RIPK3 3′UTR was amplified by PCR. The forward primer was 5′-TTCAGAGAAT CACTGCAAGAG-3′; the reverse primer was 5′-CACAGTTAACATGCTATGTTT-3′. The constructs were sequence verified. 3′UTRs were subcloned into the pGL3 vector (Promega, Madison, WI, USA) immediately downstream of the stop codon of the luciferase gene. Luciferase activity assay was performed using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions.
Constructions of mouse NRF promoter and its mutant. The NRF promoter was amplified from mouse genome using PCR. The forward primer was 5′-CAGAGTATGTAGATGGCTGTAG-3′. The reverse primer was 5′-TACACAGCTT AAGTTGTTATCG-3′. The promoter fragment was finally cloned into the vector pGL-4.17 (Promega). The introduction of mutations in the putative p53 binding site was performed with the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) using the wild-type vector as a template. The construct was sequenced to check that only the desired mutations had been introduced.
I/R, preparations of area at risk and histology. Male adult C57BL/6 mice (10 weeks old) were obtained from Institute of Laboratory Animal Science of Chinese Academy of Medical Sciences (Beijing, China). For delivery of miR-873, the mice received on three consecutive days, intravenous injections of miR-873 mimic, or its control at a dose of 30 mg/kg body weight in a small volume (0.2 ml) per injection. For intracoronary delivery of adenoviruses, the mice were anesthetized and ventilated with a HX-300S animal ventilator. The chest was entered through a small left anterior thoracotomy, the pericardial sac was then removed and 2 × 10 10 moi adenoviruses of NRF-siRNA or 2 × 10 11 moi adenoviruses of p53-siRNA were injected with a catheter from the apex of the left ventricle into the aortic root while the aorta and pulmonary arteries were crossclamped. The clamp was maintained for 20 s when the heart pumped against a closed system. After removal of air and blood, the chest was then closed and the mice were returned back to cage for recovery. Five days after the injection of adenoviruses, the mice were subjected to I/R surgery.
For I/R injury model, mice were subjected to 60 min ischemia, then 24 h or 1 week reperfusion as described. 68 The Sham-operated group experienced the same procedure except the snare was left untied. Evans blue dye was treated as described. 68 The areas of infarction (INF), area at risk (AAR) and non-ischemic left ventricle (LV) were assessed with computer-assisted planimetry (NIH Image 1.57) by an observer blinded to the sample identity. The ratio of AAR/LV and INF/AAR was calculated as described. 68 All animal experimental procedures were approved by the Animal Ethics Review Committee of QingDao University (ethics approval number 2014 QD-026).
Statistical analysis. Data are expressed as the mean ± S.E.M. of at least three independent experiments. We used a one-way analysis of variance for multiple comparisons. A value of Po0.05 was considered significant.
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